Reidun Torp

  • Associate Professor; PhD
  • +47 22 85 12 69

Original articles

Stahl K, Rahmani S, Prydz A, Skauli N, MacAulay N, Mylonakou MN, Torp R, Skare Ø, Berg T, Leergaard TB, Paulsen RE, Ottersen OP, Amiry-Moghaddam M (2018)
Targeted deletion of the aquaglyceroporin AQP9 is protective in a mouse model of Parkinson's disease
PLoS One, 13 (3), e0194896
DOI 10.1371/journal.pone.0194896, PubMed 29566083

Yang J, Zhang R, Shi C, Mao C, Yang Z, Suo Z, Torp R, Xu Y (2017)
AQP4 Association with Amyloid Deposition and Astrocyte Pathology in the Tg-ArcSwe Mouse Model of Alzheimer's Disease
J Alzheimers Dis, 57 (1), 157-169
DOI 10.3233/JAD-160957, PubMed 28222512

Nuruddin S, Syverstad GH, Lillehaug S, Leergaard TB, Nilsson LN, Ropstad E, Krogenæs A, Haraldsen IR, Torp R (2014)
Elevated mRNA-levels of gonadotropin-releasing hormone and its receptor in plaque-bearing Alzheimer's disease transgenic mice
PLoS One, 9 (8), e103607
DOI 10.1371/journal.pone.0103607, PubMed 25089901

Lillehaug S, Syverstad GH, Nilsson LN, Bjaalie JG, Leergaard TB, Torp R (2013)
Brainwide distribution and variance of amyloid-beta deposits in tg-ArcSwe mice
Neurobiol Aging, 35 (3), 556-64
DOI 10.1016/j.neurobiolaging.2013.09.013, PubMed 24126157

Nagelhus EA, Amiry-Moghaddam M, Bergersen LH, Bjaalie JG, Eriksson J, Gundersen V, Leergaard TB, Morth JP, Storm-Mathisen J, Torp R, Walhovd KB, Tønjum T (2013)
The glia doctrine: addressing the role of glial cells in healthy brain ageing
Mech Ageing Dev, 134 (10), 449-59
DOI 10.1016/j.mad.2013.10.001, PubMed 24141107

Lillenes MS, Støen M, Gómez-Muñoz M, Torp R, Günther CC, Nilsson LN, Tønjum T (2013)
Transient OGG1, APE1, PARP1 and Polβ expression in an Alzheimer's disease mouse model
Mech Ageing Dev, 134 (10), 467-77
DOI 10.1016/j.mad.2013.09.002, PubMed 24121118

Benfenati V, Pistone A, Sagnella A, Stahl K, Camassa L, Gomis-Perez C, Toffanin S, Torp R, Kaplan DL, Ruani G, Omenetto FG, Zamboni R, Muccini M (2012)
WITHDRAWN: Silk fibroin films are a bio-active interface for neuroregenerative medicine
J Appl Biomater Funct Mater, 315-323 (in press)
DOI 10.5301/JABFM.2012.10448, PubMed 23258563

Benfenati V, Stahl K, Gomis-Perez C, Toffanin S, Sagnella A, Torp R, Kaplan DL, Ruani G, Omenetto FG, Zamboni R, Muccini M (2012)
Biofunctional Silk/Neuron Interfaces
Adv. Funct. Mater., 22 (9), 1871-1884

Stahl K, Mylonakou MN, Skare Ø, Amiry-Moghaddam M, Torp R (2011)
Cytoprotective effects of growth factors: BDNF more potent than GDNF in an organotypic culture model of Parkinson's disease
Brain Res, 1378, 105-18
DOI 10.1016/j.brainres.2010.12.090, PubMed 21236244

Yang J, Lunde LK, Nuntagij P, Oguchi T, Camassa LM, Nilsson LN, Lannfelt L, Xu Y, Amiry-Moghaddam M, Ottersen OP, Torp R (2011)
Loss of astrocyte polarization in the tg-ArcSwe mouse model of Alzheimer's disease
J Alzheimers Dis, 27 (4), 711-22
DOI 10.3233/JAD-2011-110725, PubMed 21891870

Stahl K, Skare Ø, Torp R (2009)
Organotypic cultures as a model of Parkinson s disease. A twist to an old model
ScientificWorldJournal, 9, 811-21
DOI 10.1100/tsw.2009.68, PubMed 19705040

Nuntagij P, Oddo S, LaFerla FM, Kotchabhakdi N, Ottersen OP, Torp R (2009)
Amyloid deposits show complexity and intimate spatial relationship with dendrosomatic plasma membranes: an electron microscopic 3D reconstruction analysis in 3xTg-AD mice and aged canines
J Alzheimers Dis, 16 (2), 315-23
DOI 10.3233/JAD-2009-0962, PubMed 19221421

Nase G, Helm PJ, Oguchi T, Nilsson LNG, Lannfelt L, Ottersen OP, Torp R (2008)
Local impact of perivascular plaques on cerebral blood flow dynamics in a transgenic mouse model of Alzheimer's disease
PROC SPIE, 6860, 686022

Oddo S, Caccamo A, Cheng D, Jouleh B, Torp R, LaFerla FM (2007)
Genetically augmenting tau levels does not modulate the onset or progression of Abeta pathology in transgenic mice
J Neurochem, 102 (4), 1053-63
DOI 10.1111/j.1471-4159.2007.04607.x, PubMed 17472708

Biskup S, Moore DJ, Celsi F, Higashi S, West AB, Andrabi SA, Kurkinen K, Yu SW, Savitt JM, Waldvogel HJ, Faull RL, Emson PC, Torp R, Ottersen OP, Dawson TM, Dawson VL (2006)
Localization of LRRK2 to membranous and vesicular structures in mammalian brain
Ann Neurol, 60 (5), 557-69
DOI 10.1002/ana.21019, PubMed 17120249

Torp R, Singh PB, Sørensen DR, Dietrichs E, Hirschberg H (2006)
[Growth factors as neuroprotective treatment in Parkinson disease?]
Tidsskr Nor Laegeforen, 126 (7), 899-901
PubMed 16554879

Zhang L, Shimoji M, Thomas B, Moore DJ, Yu SW, Marupudi NI, Torp R, Torgner IA, Ottersen OP, Dawson TM, Dawson VL (2005)
Mitochondrial localization of the Parkinson's disease related protein DJ-1: implications for pathogenesis
Hum Mol Genet, 14 (14), 2063-73
DOI 10.1093/hmg/ddi211, PubMed 15944198

Rissman RA, Poon WW, Blurton-Jones M, Oddo S, Torp R, Vitek MP, LaFerla FM, Rohn TT, Cotman CW (2004)
Caspase-cleavage of tau is an early event in Alzheimer disease tangle pathology
J Clin Invest, 114 (1), 121-30
DOI 10.1172/JCI20640, PubMed 15232619

Review articles

Bernard-Trifilo JA, Kramár EA, Torp R, Lin CY, Pineda EA, Lynch G, Gall CM (2005)
Integrin signaling cascades are operational in adult hippocampal synapses and modulate NMDA receptor physiology
J Neurochem, 93 (4), 834-49
DOI 10.1111/j.1471-4159.2005.03062.x, PubMed 15857387

Head E, Torp R (2002)
Insights into Abeta and presenilin from a canine model of human brain aging
Neurobiol Dis, 9 (1), 1-10
DOI 10.1006/nbdi.2002.0476, PubMed 11848680


Torp R (1995)
Neuronal and glial handling of glutamate in the ischemic hippocampus: immunocytochemical and in situ hybridisation studies addressing the "glutamate hypothesis" of ischemic cell death
Department of Anatomy, Institute of Basic Medical Sciences, University of Oslo, Oslo, 1 b. (flere pag.)
BIBSYS 950518778, ISBN 82-91061-57-2

Torp R (1990)
Redistribution of transmitter amino acids during experimental brain ischemia: with special reference to the cellular and subcellular distribution of glutamate, glutamine and taurine
[ R. Torp], Oslo, 87 s.
BIBSYS 90016171x

Page visits: 3166